Saturday, 4 Oct 2025
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Subscribe
Life Care News
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
    NewsShow More
    Cummins India Limited Commemorates 30 Years of Listing on NSE
    Cummins India Limited Commemorates 30 Years of Listing on NSE
    04/10/2025
    Black Box Partners with Wind River to Accelerate Edge and Cloud Innovation Globally
    Black Box Partners with Wind River to Accelerate Edge and Cloud Innovation Globally
    04/10/2025
    10 Icons Who Inspire Change: A Celebration of Vision, Commitment & Legacy
    10 Icons Who Inspire Change: A Celebration of Vision, Commitment & Legacy
    03/10/2025
    Bitget CEO Gracy Chen Supports Inaugural UNICEF Game Jam
    Bitget CEO Gracy Chen Supports Inaugural UNICEF Game Jam
    03/10/2025
    Feedzai Accelerates AI-led Financial Crime Prevention with New Investment Round that Grows Company’s Valuation to  Billion
    Feedzai Accelerates AI-led Financial Crime Prevention with New Investment Round that Grows Company’s Valuation to $2 Billion
    02/10/2025
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
  • 🔥
  • news
  • global
  • Business
  • june
  • announced
  • today
  •  and
  • july
  •  the
  • company
Font ResizerAa
Life Care NewsLife Care News
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Search
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Health

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNews Wire
Last updated: 04/10/2025 1:32 AM
GlobeNews Wire
Share
2 Min Read
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SHARE
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 03, 2025 16:01 ET  | Source: Intellia Therapeutics, Inc.

CAMBRIDGE, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on October 1, 2025, it awarded inducement grants to six new employees under Intellia’s 2024 Inducement Plan as a material inducement to employment.

The inducement grants consisted of time-based restricted stock units (“RSUs”) for an aggregate of 65,200 shares of Intellia’s common stock, with one-third of such RSUs vesting on October 1, 2026, 2027 and 2028.

All equity vesting is subject to each employee’s continued service as an employee of, or other service provider to, Intellia through the applicable vesting dates.

All of the above-described awards were granted outside of Intellia’s stockholder-approved equity incentive plans pursuant to Intellia’s 2024 Inducement Plan, which was adopted by the board of directors in June 2024. These awards were approved by Intellia’s compensation committee as a material inducement to entering into employment with Intellia in accordance with Nasdaq Listing Rule 5635(c)(4).

About Intellia Therapeutics

Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies. Since its inception, Intellia has focused on leveraging gene editing technology to develop novel, first-in-class medicines that address important unmet medical needs and advance the treatment paradigm for patients. Intellia’s deep scientific, technical and clinical development experience, along with its people, is helping set the standard for a new class of medicine. To harness the full potential of gene editing, Intellia continues to expand the capabilities of its CRISPR-based platform with novel editing and delivery technologies. Learn more at intelliatx.com and follow us @intelliatx.

Intellia Contacts:

Investors:
Jason Fredette
Vice President, Investor Relations and Corporate Communications
jason.fredette@intelliatx.com

Media:
Matt Crenson
Ten Bridge Communications
media@intelliatx.com
mcrenson@tenbridgecommunications.com

GIGABYTE Announces Availability of 27″ QD-OLED Gaming Monitor AORUS FO27Q5P Featuring 500Hz Refresh Rate
Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025
Lamborghini FewOffs: a tradition of exclusivity for the future
COLGATE DENTAL VEER ANTHEM LAUNCHED TO EMPOWER KIDS TO BE THEIR OWN HEROES OF ORAL HEALTH
HERE Technologies and Radaro Partner to Deliver Next-Gen Route Optimisation and Tour Planning Solution for Enterprise-Grade Logistics
TAGGED:5635(c)(4)grantsinducementintellialistingnasdaqNasdaq:NTLAnewsreportsruletherapeuticsunderUS45826J1051
Share This Article
Facebook Copy Link Print
- Advertisement -

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
XFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
LinkedInFollow
MediumFollow

Most Selling Products

Top Picks, Trending Now – Discover the Best Sellers!
Tecno Camon 20 Premier 5G

Tecno Camon 20 Premier 5G

Dark Welkin | 8GB RAM + 512GB Storage (Expandable RAM up to 16GB) | Industry’s 1st 50MP RGBW-Pro Camera | Segment-First 108MP Ultra-Wide Macro Lens | 6.67" 120Hz 10-bit AMOLED In-Display

iQOO Z10 Lite 5G

iQOO Z10 Lite 5G

Titanium Blue | 6GB RAM + 128GB Storage | Dimensity 6300 5G with 433K+ AnTuTu Score | Robust 6000mAh Battery | IP64 Rated + Military-Grade Shock Resistance

OnePlus 13s

OnePlus 13s

Black Velvet | 12GB RAM + 256GB Storage | Flagship Snapdragon® 8 Elite Chipset | Exceptional Battery Life in a Compact Form | Lifetime Display Warranty Included

Samsung Galaxy A55 5G

Samsung Galaxy A55 5G

Awesome Iceblue | 8GB RAM + 256GB Storage | Premium Metal Frame | 50MP OIS Main Camera with Nightography | IP67 Water & Dust Resistance | Gorilla Glass Victus+ | sAMOLED Display with Vision Booster

You Might Also Like

Bybit & Block Scholes Report: ETH Holds Key Level as SOL Growth Stagnates
Business

Bybit & Block Scholes Report: ETH Holds Key Level as SOL Growth Stagnates

18/07/2025
SMIRNOFF AND TROYE SIVAN DROP NEW BUSINESS UPDATE FROM “VIBES HQ”, KICKING OFF ‘BRIEFCASE DROP’ SCAVENGER HUNT FOR FANS
Travel

SMIRNOFF AND TROYE SIVAN DROP NEW BUSINESS UPDATE FROM “VIBES HQ”, KICKING OFF ‘BRIEFCASE DROP’ SCAVENGER HUNT FOR FANS

23/09/2025
Regen BioPharma Discusses Potential Impact of HemaXellerate on Chemotherapy Treament Market
Health

Regen BioPharma Discusses Potential Impact of HemaXellerate on Chemotherapy Treament Market

15/08/2025
MinIO Brings Hyperscaler Economics On-Prem with AIStor Pods
Tech

MinIO Brings Hyperscaler Economics On-Prem with AIStor Pods

13/09/2025
Life Care News
Facebook Twitter Youtube Rss Medium

Life Care News:


We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Top Categories
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Usefull Links
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Copyright © 2015 – 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Life Care NewsLife Care News
Copyright © 2015 - 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?